Validation of an analytical method by high-performance liquid chromatography and microbiological assay, biological safety and in silico toxicity for danofloxacin

Detalhes bibliográficos
Autor(a) principal: Cordeiro, Everson Willian Fialho
Data de Publicação: 2020
Outros Autores: Hilgert, Renata Medeiros, Batista, Luiz Alcides das Chagas, Souza, Raul Oliveira, Oliveira, Luís Flávio Souza de, Machado, Michel Mansur, Malesuik, Marcelo Donadel, Paula, Fávero Reisdorfer, Stopiglia, Cheila Denise Ottonelli, Paim, Clésio Soldateli
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/181690
Resumo: Danofloxacin is a veterinary fluoroquinolone used to treat respiratory and gastrointestinal diseases of birds, pigs and cattle. The literature reviewed shows some analytical methods to quantify this fluoroquinolone, but microbiological and biological safety studies are limited. The analytical methods were validated by the Official Codes. The LC-DAD method was developed and validated using an RP-18 column, mobile phase containing a mixture of 0.3% triethylamine (pH 3.0) and acetonitrile (85:15, v/v). The microbiological assay was performed by agar diffusion method (3 x 3) and Staphylococcus epidermidis as a microorganism test. Forced degradation studies were performed in both methods. The minimum inhibitory concentration (MIC) was performed by test microdilution and toxicity studies were evaluated using in silico study, cell proliferation, cell viability test, micronuclei and comet assay. LC and a microbiological assay proved linear, accurate, precise, and robust to quantify danofloxacin, but only the LC method showed selectivity to quantify the drug in the presence of its degradation products. These results demonstrate that the LC method is suitable for stability studies of danofloxacin, but a microbiological assay cannot be used to quantify the drug due to the biological activity of the photoproducts. Ex-vivo cytotoxicity and theoretical and experimental genotoxicity were also observed.
id USP-31_382cd438ce62109eca149037c390acd5
oai_identifier_str oai:revistas.usp.br:article/181690
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Validation of an analytical method by high-performance liquid chromatography and microbiological assay, biological safety and in silico toxicity for danofloxacinDanofloxacinMicrobiological assayBiological safetyIn silico toxicologyFluoroquinolones photodegradationDanofloxacin is a veterinary fluoroquinolone used to treat respiratory and gastrointestinal diseases of birds, pigs and cattle. The literature reviewed shows some analytical methods to quantify this fluoroquinolone, but microbiological and biological safety studies are limited. The analytical methods were validated by the Official Codes. The LC-DAD method was developed and validated using an RP-18 column, mobile phase containing a mixture of 0.3% triethylamine (pH 3.0) and acetonitrile (85:15, v/v). The microbiological assay was performed by agar diffusion method (3 x 3) and Staphylococcus epidermidis as a microorganism test. Forced degradation studies were performed in both methods. The minimum inhibitory concentration (MIC) was performed by test microdilution and toxicity studies were evaluated using in silico study, cell proliferation, cell viability test, micronuclei and comet assay. LC and a microbiological assay proved linear, accurate, precise, and robust to quantify danofloxacin, but only the LC method showed selectivity to quantify the drug in the presence of its degradation products. These results demonstrate that the LC method is suitable for stability studies of danofloxacin, but a microbiological assay cannot be used to quantify the drug due to the biological activity of the photoproducts. Ex-vivo cytotoxicity and theoretical and experimental genotoxicity were also observed.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2020-12-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/18169010.1590/s2175-97902019000418355Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e18355Brazilian Journal of Pharmaceutical Sciences; v. 56 (2020); e18355Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e183552175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/181690/168675Copyright (c) 2020 Brazilian Journal of Pharmaceutical Scienceshttp://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessCordeiro, Everson Willian Fialho Hilgert, Renata Medeiros Batista, Luiz Alcides das Chagas Souza, Raul Oliveira Oliveira, Luís Flávio Souza de Machado, Michel Mansur Malesuik, Marcelo Donadel Paula, Fávero Reisdorfer Stopiglia, Cheila Denise Ottonelli Paim, Clésio Soldateli 2021-06-12T19:46:54Zoai:revistas.usp.br:article/181690Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2021-06-12T19:46:54Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Validation of an analytical method by high-performance liquid chromatography and microbiological assay, biological safety and in silico toxicity for danofloxacin
title Validation of an analytical method by high-performance liquid chromatography and microbiological assay, biological safety and in silico toxicity for danofloxacin
spellingShingle Validation of an analytical method by high-performance liquid chromatography and microbiological assay, biological safety and in silico toxicity for danofloxacin
Cordeiro, Everson Willian Fialho
Danofloxacin
Microbiological assay
Biological safety
In silico toxicology
Fluoroquinolones photodegradation
title_short Validation of an analytical method by high-performance liquid chromatography and microbiological assay, biological safety and in silico toxicity for danofloxacin
title_full Validation of an analytical method by high-performance liquid chromatography and microbiological assay, biological safety and in silico toxicity for danofloxacin
title_fullStr Validation of an analytical method by high-performance liquid chromatography and microbiological assay, biological safety and in silico toxicity for danofloxacin
title_full_unstemmed Validation of an analytical method by high-performance liquid chromatography and microbiological assay, biological safety and in silico toxicity for danofloxacin
title_sort Validation of an analytical method by high-performance liquid chromatography and microbiological assay, biological safety and in silico toxicity for danofloxacin
author Cordeiro, Everson Willian Fialho
author_facet Cordeiro, Everson Willian Fialho
Hilgert, Renata Medeiros
Batista, Luiz Alcides das Chagas
Souza, Raul Oliveira
Oliveira, Luís Flávio Souza de
Machado, Michel Mansur
Malesuik, Marcelo Donadel
Paula, Fávero Reisdorfer
Stopiglia, Cheila Denise Ottonelli
Paim, Clésio Soldateli
author_role author
author2 Hilgert, Renata Medeiros
Batista, Luiz Alcides das Chagas
Souza, Raul Oliveira
Oliveira, Luís Flávio Souza de
Machado, Michel Mansur
Malesuik, Marcelo Donadel
Paula, Fávero Reisdorfer
Stopiglia, Cheila Denise Ottonelli
Paim, Clésio Soldateli
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Cordeiro, Everson Willian Fialho
Hilgert, Renata Medeiros
Batista, Luiz Alcides das Chagas
Souza, Raul Oliveira
Oliveira, Luís Flávio Souza de
Machado, Michel Mansur
Malesuik, Marcelo Donadel
Paula, Fávero Reisdorfer
Stopiglia, Cheila Denise Ottonelli
Paim, Clésio Soldateli
dc.subject.por.fl_str_mv Danofloxacin
Microbiological assay
Biological safety
In silico toxicology
Fluoroquinolones photodegradation
topic Danofloxacin
Microbiological assay
Biological safety
In silico toxicology
Fluoroquinolones photodegradation
description Danofloxacin is a veterinary fluoroquinolone used to treat respiratory and gastrointestinal diseases of birds, pigs and cattle. The literature reviewed shows some analytical methods to quantify this fluoroquinolone, but microbiological and biological safety studies are limited. The analytical methods were validated by the Official Codes. The LC-DAD method was developed and validated using an RP-18 column, mobile phase containing a mixture of 0.3% triethylamine (pH 3.0) and acetonitrile (85:15, v/v). The microbiological assay was performed by agar diffusion method (3 x 3) and Staphylococcus epidermidis as a microorganism test. Forced degradation studies were performed in both methods. The minimum inhibitory concentration (MIC) was performed by test microdilution and toxicity studies were evaluated using in silico study, cell proliferation, cell viability test, micronuclei and comet assay. LC and a microbiological assay proved linear, accurate, precise, and robust to quantify danofloxacin, but only the LC method showed selectivity to quantify the drug in the presence of its degradation products. These results demonstrate that the LC method is suitable for stability studies of danofloxacin, but a microbiological assay cannot be used to quantify the drug due to the biological activity of the photoproducts. Ex-vivo cytotoxicity and theoretical and experimental genotoxicity were also observed.
publishDate 2020
dc.date.none.fl_str_mv 2020-12-09
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/181690
10.1590/s2175-97902019000418355
url https://www.revistas.usp.br/bjps/article/view/181690
identifier_str_mv 10.1590/s2175-97902019000418355
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/181690/168675
dc.rights.driver.fl_str_mv Copyright (c) 2020 Brazilian Journal of Pharmaceutical Sciences
http://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2020 Brazilian Journal of Pharmaceutical Sciences
http://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e18355
Brazilian Journal of Pharmaceutical Sciences; v. 56 (2020); e18355
Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e18355
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1800222915123216384